Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 7
Submit an article Journal homepage
92
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Experience with tenofovir disoproxil fumarate for antiretroviral therapy

Christoph Stephan Consultant Physician Hospital of the Johann Wolfgang Goethe University, Internal Medicine & Infectious Diseases, Medical HIV Treatment and Research Unit, Department of Internal Medicine II, Theodor-Stern-Kai 7, Building no. 68, 60590 Frankfurt, Germany +49 69 6301 7680; +49 69 6301 83425; [email protected]
, MD
Pages 1197-1209 | Published online: 21 Apr 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Iwen F Grigsby, Lan Pham, Louis M Mansky, Raj Gopalakrishnan & Kim C Mansky. (2010) Tenofovir-associated bone density loss. Therapeutics and Clinical Risk Management 6, pages 41-47.
Read now

Articles from other publishers (4)

Joseph M. Custodio, Marshall Fordyce, William Garner, Mona Vimal, Kah Hiing J. Ling, Brian P. Kearney & Srinivasan Ramanathan. (2016) Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment. Antimicrobial Agents and Chemotherapy 60:9, pages 5135-5140.
Crossref
Patricia M. Flynn, Mark Mirochnick, David E. Shapiro, Arlene Bardeguez, John Rodman, Brian Robbins, Sharon Huang, Susan A. Fiscus, Koen K. A. Van Rompay, James F. Rooney, Brian Kearney, Lynne M. Mofenson, D. Heather Watts, Patrick Jean-Philippe, Barbara Heckman, Edwin ThorpeJr.Jr., Amanda Cotter & Murli Purswani. (2011) Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants. Antimicrobial Agents and Chemotherapy 55:12, pages 5914-5922.
Crossref
Aoife G. Cotter & William G. Powderly. (2011) Endocrine complications of human immunodeficiency virus infection: Hypogonadism, bone disease and tenofovir-related toxicity. Best Practice & Research Clinical Endocrinology & Metabolism 25:3, pages 501-515.
Crossref
Natasza E. Ziółkowska, Christopher J. Michejda & Grzegorz D. Bujacz. (2010) Structural studies of series HIV-1 nonnucleoside reverse transcriptase inhibitors 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-benzimidazoles with different 4-substituents. Journal of Molecular Structure 966:1-3, pages 53-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.